Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lamotrigine filed by Zydus Pharmaceuticals USA Inc. The approval indicates changes under the…
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited under ANDA090401.
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Lamotrigine by Dr. Reddy's Laboratories Limited (ANDA076708), indicating a change related to the…
-
FDA approval · 2011-09-29FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-09-27FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-09-27FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for risperidone, granting approval of a generic risperidone product. This is …
-
FDA approval · 2011-09-24FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved Janssen's supplemental application for Risperdal M-TAB (risperidone), adding the M-TAB dosage form to the approved product.…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, signaling an approved update to the…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action represents a regul…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2011-08-26FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Risperidone by Torrent Pharmaceuticals Limited, indicating approval of a generic version of the …
-
FDA approval · 2011-08-25FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' supplemental application for risperidone, authorizing a generic version of the antipsychotic. The …
-
FDA approval · 2011-08-24FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
The FDA approved a supplemental application for risperidone from Janssen Pharmaceuticals, Inc. The approval updates the drug's labeling.
-
FDA approval · 2011-08-24FDA Approved: RISPERIDONE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA's generic risperidone (ANDA201003).
-
FDA approval · 2011-08-22FDA Approved: CARBATROL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for CARBATROL (carbamazepine) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-08-16FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Risperidone from Torrent Pharmaceuticals Limited, authorizing changes to the approved generic pr…
-
FDA approval · 2011-08-09FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
The FDA approved Amici Pharma, Inc.'s supplemental application for risperidone, authorizing a generic version of the antipsychotic under an …
-
FDA approval · 2011-08-04FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) submitted by GlaxoSmithKline LLC. The action updates the product's ap…
-
FDA approval · 2011-08-04FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL XR (lamotrigine) from GlaxoSmithKline LLC, authorizing changes to the product labeling.
-
FDA approval · 2011-07-11FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for Risperidone by Zydus Lifesciences Limited, confirming regulatory approval of changes to the prod…
-
FDA approval · 2011-07-08FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC.
-
FDA approval · 2011-06-30FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approves a supplemental application for generic risperidone by Jubilant Cadista Pharmacuticals Inc., enabling the generic product to…
-
FDA approval · 2011-06-30FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone (RISPERIDONE). This action approves the generic pro…
-
FDA approval · 2011-06-21FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal XR (lamotrigine) from GlaxoSmithKline LLC. The approval updates the labeling/indication…
-
FDA approval · 2011-06-15FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
The FDA approved Janssen Pharmaceutical, Inc.'s supplemental application for risperidone, resulting in updated labeling.